866-997-4948(US-Canada Toll Free)

2017-2022 Global and Japan Hormonal drugs Market Analysis Report

Published By :

Jp Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 127 Pages

The global Hormonal drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Hormonal drugs market's development status and future trend in the global and Japan. It splits Hormonal drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
Alcon NV
Allergan Pharmaceuticals Ireland
AstraZeneca Pty Ltd
Bausch & Lomb Incorporated
BEECHAM GROUP PLC
Berlin-Chemie AG
Biofer S.p.A.
Bright Future Pharmaceuticals Factory
Chiesi Farmaceutici S.p.A.
FARMABIOS S.P.A.
GLAXO WELLCOME UK LIMITED
GlaxoSmithKline Australia Pty Ltd
Herbrand PharmaChemicals GmbH
Laboratoire GlaxoSmithKline
LEO Pharma A/S
Merck Serono GmbH
Mitsubishi Tanabe Pharma Corporation
MSD Merck Sharp & Dohme AG
NANG KUANG PHARMCEUTICAL CO., LTD
Newchem S.p.A.
NEWCHEM SPA
Orion Corporation
Pfizer Italia s.r.l
Pharmacia & Upjohn Co.,
SAMCHUNDANG PHARM. CO.,LTD.
Santen Pharmaceutical Co.,Ltd.
Sicor Societa Italiana Corticosteroidi S.R.L
SYNMOSA BIOPHARMA CORPORATION

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Hormonal drugs market is primarily split into
Hormonal drugs Market, by Glucocorticoid
Cortisone
Hydrocortisone
Cortisol
Hydrocortisone Butyrate
Budesonide
Ciclesonide
Deflazacort
Medrysone
Tixocortol
Cloprednol
Halcinonide
Rimexolone
Flunisolide
Trianmcinolon
Amcinonide
Fluocinonide
Meprednisone
Fluorometholone
Fluocortolone
Fluocortin
Desoximetasone
Methylprednisolone
Prednicarbate
Prednylidene
Ciclesonide
Fluprednisolone
Dexamethasone
Betamethasone
Clobetasol
Clobetasone
Diflorasone
Fluperolone
Halometasone
Ulobetasol
Beclomethasone
Paramethasone
Alclometasone
Fluclorolone acetonide
Fluprednidene
Cortivazol
Fluticasone
Loteprednol
Fludroxycortide
Formocortal
Mometasone

Hormonal drugs Market, by Mineralocorticoids
Fludrocortisone
Aldosterone

Hormonal drugs Market, by Aldosterone receptor antagoni
Spironolactone
Eplerenone
Canrenoate Potassium
Canrenone

Hormonal drugs Market, by Synthetic modifier
Trilostane
Carbenoxolone
Aminoglutethimide
Metyrapone

Hormonal drugs Market, by Thyroid hormone and thyroid m
Thyroid Tablets
Liothyronine
Levothyroxine sodium
Methylthiouracil
Carbimazole
Methimazole
Propylthiouracil
Lugol's solution
Propranolol


Key Applications
Pharmacy
Hospital
Department of endocrinology
Department of dermatology
infectious disease department


Table of Contents



2017-2022 Global and Japan Hormonal drugs Market Analysis Report

1 Hormonal drugs Overview

1.1 Product Overview and Scope of Hormonal drugs

1.2 Global and Japan Hormonal drugs Market by Applications/End Users

1.2.1 Japan Hormonal drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.1.1 Japan Hormonal drugs Sales () and Market Share by Applications (2012-2017)

1.2.1.2 Japan Hormonal drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.1.3 Market Drivers and Opportunities

1.2.2 Japan Hormonal drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.3 Global Hormonal drugs Sales by Application (2012-2017)

1.2.3.1 Global Hormonal drugs Sales () and Market Share by Applications (2012-2017)

1.2.3.2 Global Hormonal drugs Sales Growth Rate (%) by Applications (2012-2017)

1.2.3.3 Market Drivers and Opportunities

1.2.4 Global Hormonal drugs Sales () and Market Share Comparison by Applications (2012-2017)

1.2.5 Pharmacy

1.2.6 Hospital

1.2.7 Department of endocrinology

1.2.8 Department of dermatology

1.2.9 infectious disease department

1.3 Global and Japan Market Size (Sales and Revenue) of Hormonal drugs (2012-2017)

1.3.1 Japan Market Size (Sales and Revenue) of Hormonal drugs (2012-2017)

1.3.1.1 Japan Hormonal drugs Sales () and Growth Rate (%) (2012-2017)

1.3.1.2 Japan Hormonal drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.3.2 Global Market Size (Sales and Revenue) of Hormonal drugs (2012-2017)

1.3.2.1 Global Hormonal drugs Sales () and Growth Rate (%) (2012-2017)

1.3.2.2 Global Hormonal drugs Revenue (Million USD) and Growth Rate (2012-2017)

1.4 Global and Japan Classification of Hormonal drugs by Glucocorticoid

1.4.1 Japan Hormonal drugs Sales () and Market Share by Glucocorticoid (2012-2017)

1.4.2 Global Hormonal drugs Sales () and Market Share by Glucocorticoid (2012-2017)

1.4.3 Japan Hormonal drugs Revenue (Million USD) and Market Share by Glucocorticoid (2012-2017)

1.4.4 Global Hormonal drugs Revenue (Million USD) and Market Share by Glucocorticoid (2012-2017)

1.4.5 Japan Hormonal drugs Price () by Glucocorticoid (2012-2017)

1.4.6 Global Hormonal drugs Price () by Glucocorticoid (2012-2017)

1.4.7 Japan Hormonal drugs Sales Growth Rate (%) by Glucocorticoid (2012-2017)

1.4.8 Global Hormonal drugs Sales Growth Rate (%) by Glucocorticoid (2012-2017)



1.5 Global and Japan Classification of Hormonal drugs by Mineralocorticoids

1.5.1 Japan Hormonal drugs Sales () and Market Share by Mineralocorticoids (2012-2017)

1.5.2 Global Hormonal drugs Sales () and Market Share by Mineralocorticoids (2012-2017)

1.5.3 Japan Hormonal drugs Revenue (Million USD) and Market Share by Mineralocorticoids (2012-2017)

1.5.4 Global Hormonal drugs Revenue (Million USD) and Market Share by Mineralocorticoids (2012-2017)

1.5.5 Japan Hormonal drugs Price () by Mineralocorticoids (2012-2017)

1.5.6 Global Hormonal drugs Price () by Mineralocorticoids (2012-2017)

1.5.7 Japan Hormonal drugs Sales Growth Rate (%) by Mineralocorticoids (2012-2017)

1.5.8 Global Hormonal drugs Sales Growth Rate (%) by Mineralocorticoids (2012-2017)



1.6 Global and Japan Classification of Hormonal drugs by Aldosterone receptor antagonis

1.6.1 Japan Hormonal drugs Sales () and Market Share by Aldosterone receptor antagonis (2012-2017)

1.6.2 Global Hormonal drugs Sales () and Market Share by Aldosterone receptor antagonis (2012-2017)

1.6.3 Japan Hormonal drugs Revenue (Million USD) and Market Share by Aldosterone receptor antagonis (2012-2017)

1.6.4 Global Hormonal drugs Revenue (Million USD) and Market Share by Aldosterone receptor antagonis (2012-2017)

1.6.5 Japan Hormonal drugs Price () by Aldosterone receptor antagonis (2012-2017)

1.6.6 Global Hormonal drugs Price () by Aldosterone receptor antagonis (2012-2017)

1.6.7 Japan Hormonal drugs Sales Growth Rate (%) by Aldosterone receptor antagonis (2012-2017)

1.6.8 Global Hormonal drugs Sales Growth Rate (%) by Aldosterone receptor antagonis (2012-2017)



1.7 Global and Japan Classification of Hormonal drugs by Synthetic modifier

1.7.1 Japan Hormonal drugs Sales () and Market Share by Synthetic modifier (2012-2017)

1.7.2 Global Hormonal drugs Sales () and Market Share by Synthetic modifier (2012-2017)

1.7.3 Japan Hormonal drugs Revenue (Million USD) and Market Share by Synthetic modifier (2012-2017)

1.7.4 Global Hormonal drugs Revenue (Million USD) and Market Share by Synthetic modifier (2012-2017)

1.7.5 Japan Hormonal drugs Price () by Synthetic modifier (2012-2017)

1.7.6 Global Hormonal drugs Price () by Synthetic modifier (2012-2017)

1.7.7 Japan Hormonal drugs Sales Growth Rate (%) by Synthetic modifier (2012-2017)

1.7.8 Global Hormonal drugs Sales Growth Rate (%) by Synthetic modifier (2012-2017)



1.8 Global and Japan Classification of Hormonal drugs by Thyroid hormone and thyroid me

1.8.1 Japan Hormonal drugs Sales () and Market Share by Thyroid hormone and thyroid me (2012-2017)

1.8.2 Global Hormonal drugs Sales () and Market Share by Thyroid hormone and thyroid me (2012-2017)

1.8.3 Japan Hormonal drugs Revenue (Million USD) and Market Share by Thyroid hormone and thyroid me (2012-2017)

1.8.4 Global Hormonal drugs Revenue (Million USD) and Market Share by Thyroid hormone and thyroid me (2012-2017)

1.8.5 Japan Hormonal drugs Price () by Thyroid hormone and thyroid me (2012-2017)

1.8.6 Global Hormonal drugs Price () by Thyroid hormone and thyroid me (2012-2017)

1.8.7 Japan Hormonal drugs Sales Growth Rate (%) by Thyroid hormone and thyroid me (2012-2017)

1.8.8 Global Hormonal drugs Sales Growth Rate (%) by Thyroid hormone and thyroid me (2012-2017)





2 Global and Japan Hormonal drugs Market Competition by Players/Manufacturers

2.1 Japan Hormonal drugs Market Competition by Players/Manufacturers

2.1.1 Japan Hormonal drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.1.2 Japan Hormonal drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.1.3 Japan Hormonal drugs Average Price () by Players/Manufacturers (2012-2017)

2.1.4 Japan Hormonal drugs Market Competitive Situation and Trends

2.1.4.1 Japan Hormonal drugs Market Concentration Rate

2.1.4.2 Japan Hormonal drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market

2.1.5 Japan Players/Manufacturers Hormonal drugs Manufacturing Base Distribution, Sales Area, Product Types

2.2 Global Hormonal drugs Market Competition by Players/Manufacturers

2.2.1 Global Hormonal drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2.2 Global Hormonal drugs Revenue and Share by Players/Manufacturers (2012-2017)

2.2.3 Global Hormonal drugs Average Price () by Players/Manufacturers (2012-2017)

2.2.4 Global Hormonal drugs Market Competitive Situation and Trends

2.2.4.1 Global Hormonal drugs Market Concentration Rate

2.2.4.2 Global Hormonal drugs Market Share of Top 3 and Top 5 Players/Manufacturers

2.2.4.3 Mergers & Acquisitions, Expansion in Global Market

2.2.5 Global Players/Manufacturers Hormonal drugs Manufacturing Base Distribution, Sales Area, Product Types



3 Global and Japan Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.1 Asia Pacific Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.1.1 Japan Hormonal drugs Sales and Revenue (2012-2017)

3.1.1.1 Japan Hormonal drugs Sales () and Market Share (2012-2017)

3.1.1.2 Japan Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.1.3 Japan Hormonal drugs Price ()(2012-2017)

3.1.2 China Hormonal drugs Sales and Revenue (2012-2017)

3.1.2.1 China Hormonal drugs Sales () and Market Share (2012-2017)

3.1.2.2 China Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.2.3 China Hormonal drugs Price ()(2012-2017)

3.1.3 Korea Hormonal drugs Sales and Revenue (2012-2017)

3.1.3.1 Korea Hormonal drugs Sales () and Market Share (2012-2017)

3.1.3.2 Korea Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.3.3 Korea Hormonal drugs Price ()(2012-2017)

3.1.4 India Hormonal drugs Sales and Revenue (2012-2017)

3.1.4.1 India Hormonal drugs Sales () and Market Share (2012-2017)

3.1.4.2 India Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.4.3 India Hormonal drugs Price ()(2012-2017)

3.1.5 Others Hormonal drugs Sales and Revenue (2012-2017)

3.1.5.1 Others Hormonal drugs Sales () and Market Share (2012-2017)

3.1.5.2 Others Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.1.5.3 Others Hormonal drugs Price ()(2012-2017)

3.2 Europe Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.2.1 France Hormonal drugs Sales and Revenue (2012-2017)

3.2.1.1 France Hormonal drugs Sales () and Market Share (2012-2017)

3.2.1.2 France Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.1.3 France Hormonal drugs Price ()(2012-2017)

3.2.2 Germany Hormonal drugs Sales and Revenue (2012-2017)

3.2.2.1 Germany Hormonal drugs Sales () and Market Share (2012-2017)

3.2.2.2 Germany Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.2.3 Germany Hormonal drugs Price ()(2012-2017)

3.2.3 United Kingdom Hormonal drugs Sales and Revenue (2012-2017)

3.2.3.1 United Kingdom Hormonal drugs Sales () and Market Share (2012-2017)

3.2.3.2 United Kingdom Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.3.3 United Kingdom Hormonal drugs Price ()(2012-2017)

3.2.4 Italy Hormonal drugs Sales and Revenue (2012-2017)

3.2.4.1 Italy Hormonal drugs Sales () and Market Share (2012-2017)

3.2.4.2 Italy Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.4.3 Italy Hormonal drugs Price ()(2012-2017)

3.2.5 Russia Hormonal drugs Sales and Revenue (2012-2017)

3.2.5.1 Russia Hormonal drugs Sales () and Market Share (2012-2017)

3.2.5.2 Russia Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.5.3 Russia Hormonal drugs Price ()(2012-2017)

3.2.6 Others Hormonal drugs Sales and Revenue (2012-2017)

3.2.6.1 Others Hormonal drugs Sales () and Market Share (2012-2017)

3.2.6.2 Others Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.2.6.3 Others Hormonal drugs Price ()(2012-2017)

3.3 North America Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.3.1 United States Hormonal drugs Sales and Revenue (2012-2017)

3.3.1.1 United States Hormonal drugs Sales () and Market Share (2012-2017)

3.3.1.2 United States Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.1.3 United States Hormonal drugs Price ()(2012-2017)

3.3.2 Canada Hormonal drugs Sales and Revenue (2012-2017)

3.3.2.1 Canada Hormonal drugs Sales () and Market Share (2012-2017)

3.3.2.2 Canada Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.3.2.3 Canada Hormonal drugs Price ()(2012-2017)

3.4 Latin America Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.4.1 Brazil Hormonal drugs Sales and Revenue (2012-2017)

3.4.1.1 Brazil Hormonal drugs Sales () and Market Share (2012-2017)

3.4.1.2 Brazil Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.1.3 Brazil Hormonal drugs Price ()(2012-2017)

3.4.2 Mexico Hormonal drugs Sales and Revenue (2012-2017)

3.4.2.1 Mexico Hormonal drugs Sales () and Market Share (2012-2017)

3.4.2.2 Mexico Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.2.3 Mexico Hormonal drugs Price ()(2012-2017)

3.4.3 Others Hormonal drugs Sales and Revenue (2012-2017)

3.4.3.1 Others Hormonal drugs Sales () and Market Share (2012-2017)

3.4.3.2 Others Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.4.3.3 Others Hormonal drugs Price ()(2012-2017)

3.5 Southeast Asia Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.5.1 Singapore Hormonal drugs Sales and Revenue (2012-2017)

3.5.1.1 Singapore Hormonal drugs Sales () and Market Share (2012-2017)

3.5.1.2 Singapore Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.1.3 Singapore Hormonal drugs Price ()(2012-2017)

3.5.2 Malaysia Hormonal drugs Sales and Revenue (2012-2017)

3.5.2.1 Malaysia Hormonal drugs Sales () and Market Share (2012-2017)

3.5.2.2 Malaysia Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.2.3 Malaysia Hormonal drugs Price ()(2012-2017)

3.5.3 Vietnam Hormonal drugs Sales and Revenue (2012-2017)

3.5.3.1 Vietnam Hormonal drugs Sales () and Market Share (2012-2017)

3.5.3.2 Vietnam Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.3.3 Vietnam Hormonal drugs Price ()(2012-2017)

3.5.4 Myanmar Hormonal drugs Sales and Revenue (2012-2017)

3.5.4.1 Myanmar Hormonal drugs Sales () and Market Share (2012-2017)

3.5.4.2 Myanmar Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.4.3 Myanmar Hormonal drugs Price ()(2012-2017)

3.5.5 Thailand Hormonal drugs Sales and Revenue (2012-2017)

3.5.5.1 Thailand Hormonal drugs Sales () and Market Share (2012-2017)

3.5.5.2 Thailand Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.5.3 Thailand Hormonal drugs Price ()(2012-2017)

3.5.6 Indonesia Hormonal drugs Sales and Revenue (2012-2017)

3.5.6.1 Indonesia Hormonal drugs Sales () and Market Share (2012-2017)

3.5.6.2 Indonesia Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.6.3 Indonesia Hormonal drugs Price ()(2012-2017)

3.5.7 Philippines Hormonal drugs Sales and Revenue (2012-2017)

3.5.7.1 Philippines Hormonal drugs Sales () and Market Share (2012-2017)

3.5.7.2 Philippines Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.7.3 Philippines Hormonal drugs Price ()(2012-2017)

3.5.8 Others Hormonal drugs Sales and Revenue (2012-2017)

3.5.8.1 Others Hormonal drugs Sales () and Market Share (2012-2017)

3.5.8.2 Others Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.5.8.3 Others Hormonal drugs Price ()(2012-2017)

3.6 Middle East & Africa Hormonal drugs Sales and Revenue by Regions (2012-2017)

3.6.1 Saudi Arabia Hormonal drugs Sales and Revenue (2012-2017)

3.6.1.1 Saudi Arabia Hormonal drugs Sales () and Market Share (2012-2017)

3.6.1.2 Saudi Arabia Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.1.3 Saudi Arabia Hormonal drugs Price ()(2012-2017)

3.6.2 Iran Hormonal drugs Sales and Revenue (2012-2017)

3.6.2.1 Iran Hormonal drugs Sales () and Market Share (2012-2017)

3.6.2.2 Iran Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.2.3 Iran Hormonal drugs Price ()(2012-2017)

3.6.3 UAE Hormonal drugs Sales and Revenue (2012-2017)

3.6.3.1 UAE Hormonal drugs Sales () and Market Share (2012-2017)

3.6.3.2 UAE Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.3.3 UAE Hormonal drugs Price ()(2012-2017)

3.6.4 Turkey Hormonal drugs Sales and Revenue (2012-2017)

3.6.4.1 Turkey Hormonal drugs Sales () and Market Share (2012-2017)

3.6.4.2 Turkey Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.4.3 Turkey Hormonal drugs Price ()(2012-2017)

3.6.5 Israel Hormonal drugs Sales and Revenue (2012-2017)

3.6.5.1 Israel Hormonal drugs Sales () and Market Share (2012-2017)

3.6.5.2 Israel Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.5.3 Israel Hormonal drugs Price ()(2012-2017)

3.6.6 Egypt Hormonal drugs Sales and Revenue (2012-2017)

3.6.6.1 Egypt Hormonal drugs Sales () and Market Share (2012-2017)

3.6.6.2 Egypt Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.6.3 Egypt Hormonal drugs Price ()(2012-2017)

3.6.7 South Africa Hormonal drugs Sales and Revenue (2012-2017)

3.6.7.1 South Africa Hormonal drugs Sales () and Market Share (2012-2017)

3.6.7.2 South Africa Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.7.3 South Africa Hormonal drugs Price ()(2012-2017)

3.6.8 Others Hormonal drugs Sales and Revenue (2012-2017)

3.6.8.1 Others Hormonal drugs Sales () and Market Share (2012-2017)

3.6.8.2 Others Hormonal drugs Revenue (Million USD) and Market Share (2012-2017)

3.6.8.3 Others Hormonal drugs Price ()(2012-2017)



4 Global and Japan Hormonal drugs Players/Manufacturers Profiles and Sales Data

4.1 Alcon NV

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Hormonal drugs Product Category, Application and Specification

4.1.2.1 Product A

4.1.2.2 Product B

4.1.3 Alcon NV Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.1.4 Main Business/Business Overview

4.2 Allergan Pharmaceuticals Ireland

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Hormonal drugs Product Category, Application and Specification

4.2.2.1 Product A

4.2.2.2 Product B

4.2.3 Allergan Pharmaceuticals Ireland Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.2.4 Main Business/Business Overview

4.3 AstraZeneca Pty Ltd

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Hormonal drugs Product Category, Application and Specification

4.3.2.1 Product A

4.3.2.2 Product B

4.3.3 AstraZeneca Pty Ltd Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.3.4 Main Business/Business Overview

4.4 Bausch & Lomb Incorporated

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Hormonal drugs Product Category, Application and Specification

4.4.2.1 Product A

4.4.2.2 Product B

4.4.3 Bausch & Lomb Incorporated Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.4.4 Main Business/Business Overview

4.5 BEECHAM GROUP PLC

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Hormonal drugs Product Category, Application and Specification

4.5.2.1 Product A

4.5.2.2 Product B

4.5.3 BEECHAM GROUP PLC Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.5.4 Main Business/Business Overview

4.6 Berlin-Chemie AG

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Hormonal drugs Product Category, Application and Specification

4.6.2.1 Product A

4.6.2.2 Product B

4.6.3 Berlin-Chemie AG Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.6.4 Main Business/Business Overview

4.7 Biofer S.p.A.

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Hormonal drugs Product Category, Application and Specification

4.7.2.1 Product A

4.7.2.2 Product B

4.7.3 Biofer S.p.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.7.4 Main Business/Business Overview

4.8 Bright Future Pharmaceuticals Factory

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Hormonal drugs Product Category, Application and Specification

4.8.2.1 Product A

4.8.2.2 Product B

4.8.3 Bright Future Pharmaceuticals Factory Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.8.4 Main Business/Business Overview

4.9 Chiesi Farmaceutici S.p.A.

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Hormonal drugs Product Category, Application and Specification

4.9.2.1 Product A

4.9.2.2 Product B

4.9.3 Chiesi Farmaceutici S.p.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.9.4 Main Business/Business Overview

4.10 FARMABIOS S.P.A.

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Hormonal drugs Product Category, Application and Specification

4.10.2.1 Product A

4.10.2.2 Product B

4.10.3 FARMABIOS S.P.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

4.10.4 Main Business/Business Overview

4.11 GLAXO WELLCOME UK LIMITED

4.12 GlaxoSmithKline Australia Pty Ltd

4.13 Herbrand PharmaChemicals GmbH

4.14 Laboratoire GlaxoSmithKline

4.15 LEO Pharma A/S

4.16 Merck Serono GmbH

4.17 Mitsubishi Tanabe Pharma Corporation

4.18 MSD Merck Sharp & Dohme AG

4.19 NANG KUANG PHARMCEUTICAL CO., LTD

4.20 Newchem S.p.A.

4.21 NEWCHEM SPA

4.22 Orion Corporation

4.23 Pfizer Italia s.r.l

4.24 Pharmacia & Upjohn Co.,

4.25 SAMCHUNDANG PHARM. CO.,LTD.

4.26 Santen Pharmaceutical Co.,Ltd.

4.27 Sicor Societa Italiana Corticosteroidi S.R.L

4.28 SYNMOSA BIOPHARMA CORPORATION



5 Hormonal drugs Manufacturing Cost Analysis

5.1 Hormonal drugs Key Raw Materials Analysis

5.1.1 Key Raw Materials

5.1.2 Price Trend of Key Raw Materials

5.1.3 Key Suppliers of Raw Materials

5.1.4 Market Concentration Rate of Raw Materials

5.2 Proportion of Manufacturing Cost Structure

5.2.1 Raw Materials

5.2.2 Labor Cost

5.2.3 Manufacturing Expenses

5.3 Manufacturing Process Analysis of Hormonal drugs



6 Industrial Chain, Sourcing Strategy and Downstream Buyers

6.1 Hormonal drugs Industrial Chain Analysis

6.2 Upstream Raw Materials Sourcing

6.3 Raw Materials Sources of Hormonal drugs Major Players/Manufacturers in 2016

6.4 Downstream Buyers



7 Marketing Strategy Analysis, Distributors/Traders

7.1 Marketing Channel

7.1.1 Direct Marketing

7.1.2 Indirect Marketing

7.1.3 Marketing Channel Development Trend

7.2 Market Positioning

7.2.1 Pricing Strategy

7.2.2 Brand Strategy

7.2.3 Target Client

7.3 Distributors/Traders List



8 Market Effect Factors Analysis

8.1 Technology Progress/Risk

8.1.1 Substitutes Threat

8.1.2 Technology Progress in Related Industry

8.2 Consumer Needs/Customer Preference Change

8.3 Economic/Political Environmental Change



9 Global and Japan Hormonal drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global and Japan Hormonal drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global and Japan Hormonal drugs Sales () Forecast by Type (2017-2022)

9.2.1 by Glucocorticoid

9.2.2 by Mineralocorticoids

9.2.3 by Aldosterone receptor antagonis

9.2.4 by Synthetic modifier

9.2.5 by Thyroid hormone and thyroid me

9.3 Global and Japan Hormonal drugs Sales () Forecast by Application (2017-2022)

9.4 Global and Japan Hormonal drugs Sales () Forecast by Regions (2017-2022)



10 Research Findings and Conclusion



11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Disclaimer

11.4 Author List





List of Table

List of Tables and Figures



Figure Product Picture of Hormonal drugs

Table Japan Hormonal drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Japan Sales Market Share (%) of Hormonal drugs by Applications in 2016

Table Global Hormonal drugs Sales (Million Units) Comparison by Applications (2012-2017)

Figure Global Sales Market Share (%) of Hormonal drugs by Applications in 2016

Figure Pharmacy Examples

Table Key Downstream Customer in Pharmacy

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Department of endocrinology Examples

Table Key Downstream Customer in Department of endocrinology

Figure Department of dermatology Examples

Table Key Downstream Customer in Department of dermatology

Figure infectious disease department Examples

Table Key Downstream Customer in infectious disease department

Figure Cortisone Product Picture

Figure Product Picture

Figure Fludrocortisone Product Picture

Figure Product Picture

Figure Spironolactone Product Picture

Figure Product Picture

Figure Trilostane Product Picture

Figure Product Picture

Figure Product Picture

Table Alcon NV Basic Information List

Table Alcon NV Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Alcon NV Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Alcon NV Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Alcon NV Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Allergan Pharmaceuticals Ireland Basic Information List

Table Allergan Pharmaceuticals Ireland Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Allergan Pharmaceuticals Ireland Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Allergan Pharmaceuticals Ireland Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Allergan Pharmaceuticals Ireland Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table AstraZeneca Pty Ltd Basic Information List

Table AstraZeneca Pty Ltd Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table AstraZeneca Pty Ltd Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table AstraZeneca Pty Ltd Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure AstraZeneca Pty Ltd Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Bausch & Lomb Incorporated Basic Information List

Table Bausch & Lomb Incorporated Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Bausch & Lomb Incorporated Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Bausch & Lomb Incorporated Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Bausch & Lomb Incorporated Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table BEECHAM GROUP PLC Basic Information List

Table BEECHAM GROUP PLC Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table BEECHAM GROUP PLC Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table BEECHAM GROUP PLC Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure BEECHAM GROUP PLC Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Berlin-Chemie AG Basic Information List

Table Berlin-Chemie AG Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Berlin-Chemie AG Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Berlin-Chemie AG Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Berlin-Chemie AG Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Biofer S.p.A. Basic Information List

Table Biofer S.p.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Biofer S.p.A. Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Biofer S.p.A. Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Biofer S.p.A. Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Bright Future Pharmaceuticals Factory Basic Information List

Table Bright Future Pharmaceuticals Factory Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Bright Future Pharmaceuticals Factory Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Bright Future Pharmaceuticals Factory Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Bright Future Pharmaceuticals Factory Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table Chiesi Farmaceutici S.p.A. Basic Information List

Table Chiesi Farmaceutici S.p.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table FARMABIOS S.P.A. Basic Information List

Table FARMABIOS S.P.A. Hormonal drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Table FARMABIOS S.P.A. Hormonal drugs Sales Growth Rate (%)(2012-2017)

Table FARMABIOS S.P.A. Hormonal drugs Sales Market Share (%) in Japan (2012-2017)

Figure FARMABIOS S.P.A. Hormonal drugs Revenue Market Share (%) in Japan (2012-2017)

Table GLAXO WELLCOME UK LIMITED Basic Information List

Table GlaxoSmithKline Australia Pty Ltd Basic Information List

Table Herbrand PharmaChemicals GmbH Basic Information List

Table Laboratoire GlaxoSmithKline Basic Information List

Table LEO Pharma A/S Basic Information List

Table Merck Serono GmbH Basic Information List

Table Mitsubishi Tanabe Pharma Corporation Basic Information List

Table MSD Merck Sharp & Dohme AG Basic Information List

Table NANG KUANG PHARMCEUTICAL CO., LTD Basic Information List

Table Newchem S.p.A. Basic Information List

Table NEWCHEM SPA Basic Information List

Table Orion Corporation Basic Information List

Table Pfizer Italia s.r.l Basic Information List

Table Pharmacia & Upjohn Co., Basic Information List

Table SAMCHUNDANG PHARM. CO.,LTD. Basic Information List

Table Santen Pharmaceutical Co.,Ltd. Basic Information List

Table Sicor Societa Italiana Corticosteroidi S.R.L Basic Information List

Table SYNMOSA BIOPHARMA CORPORATION Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Hormonal drugs

Figure Manufacturing Process Analysis of Hormonal drugs

Figure Hormonal drugs Industrial Chain Analysis

Table Raw Materials Sources of Hormonal drugs Major Players/Manufacturers in 2016

Table Major Buyers of Hormonal drugs

Table Distributors/Traders List

Figure Japan Hormonal drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Japan Hormonal drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Hormonal drugs Price () Trend Forecast (2017-2022)

Figure Global Hormonal drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Hormonal drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Hormonal drugs Price () Trend Forecast (2017-2022)

Table Japan Hormonal drugs Sales () Forecast by Type (2017-2022)

Table Global Hormonal drugs Sales () Forecast by Type (2017-2022)

Figure Japan Hormonal drugs Sales () Forecast by Type (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Type (2017-2022)

Figure Japan Hormonal drugs Sales Volume Market Share Forecast by Type in 2017

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Type in 2017

Table Japan Hormonal drugs Sales () Forecast by Application (2017-2022)

Figure Japan Hormonal drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Japan Hormonal drugs Sales Volume Market Share Forecast by Application in 2017

Table Global Hormonal drugs Sales () Forecast by Application (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application in 2017

Table Japan Hormonal drugs Sales () Forecast by Regions (2017-2022)

Table Japan Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Japan Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Global Hormonal drugs Sales () Forecast by Regions (2017-2022)

Table Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources



Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *